skip to Main Content

MedData Newsletter: June 2017

WWDC17: Full Recap

Tyler Hugenberg, Duet Health’s Lead iOS Engineer is back from his trip to Apple’s Annual Worldwide Developer’s Conference (WWDC17) in San Jose,CA. During his time at WWDC17 Tyler networked with iOS Engineers from Apple, Facebook, Google, LinkedIn, Adobe, and Oracle, but also had conversations about the exciting path healthcare tech is headed down with engineers working in start-ups much like Duet.

Healthcare was a large topic of discussion, although not as featured in the keynote sessions as in previous years. Third party device connectivity and interaction were featured, specifically the new features the Apple Watch will launch to determine and notify things like low blood sugar. There will also be more personalized goals surrounding personal fitness and well-being.

As expected, the keynote speakers and sessions did not disappoint. Hugenberg’s favorite sessions included a Virtual Reality Demo featuring Star Wars by ILM VFX Supervisor John Knoll and Epic’s Lauren Ridge and a demo featuring the Augmented Reality features implemented in iOS 11.

“Over all, it was a truly awesome experience that I am honored to be a part of. I am back with a notebook full of technical notes and a ton of inspiration!” Hugenberg said.

Learn more about WWDC and watch all the demos »

Upcoming Events

HFMA ANI 2017 in Orlando

Are you attending HFMA’s National Institute June 25-28 in Orlando?

Stop by our booth #1821 and enjoy some sweet treats and grab a quick selfie with some Disney favorites! Plus, you can get a chance to find out how MedData’s full suite of technology-enabled solutions can boost your bottom line.

Learn more about HFMA ANI »

Startup Grind Columbus Hosts Duet Health’s, Jeff Harper

Check out Jeff Harper’s, CEO & Co-Founder of Duet Health, full interview, hosted by Startup Grind during Columbus Startup Week 2017 and get an inside look at where Duet began, how far it has come and the exciting things coming soon!

Watch the full interview» 

This Post Has 0 Comments

Leave a Reply